UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 619

Sortiert nach

Cost-effectiveness of Universal Hepatitis C Virus Screening of Pregnant Women in the United States

Clinical infectious diseases, 2019-11, Vol.69 (11), p.1888-1895

2019

Volltextzugriff (PDF)

Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region

PloS one, 2021-11, Vol.16 (11), p.e0260286

2021

Volltextzugriff (PDF)

Responding to global stimulant use: challenges and opportunities

The Lancet (British edition), 2019-11, Vol.394 (10209), p.1652-1667

2019

Volltextzugriff (PDF)

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

Journal of hepatology, 2016-07, Vol.65 (1), p.17-25

2016

Volltextzugriff (PDF)

The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia

The Lancet (British edition), 2016-09, Vol.388 (10050), p.1228-1248

2016

Volltextzugriff (PDF)

Mathematical modeling of hepatitis c virus (HCV) prevention among people who inject drugs: A review of the literature and insights for elimination strategies

Journal of theoretical biology, 2019-11, Vol.481, p.194-201

2019

Volltextzugriff (PDF)

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy

Clinical infectious diseases, 2013-08, Vol.57 (suppl_2), p.S39-S45

2013

Volltextzugriff (PDF)

The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?

PloS one, 2016-05, Vol.11 (5), p.e0156213

2016

Volltextzugriff (PDF)

Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review

BMJ (Online), 2016-10, Vol.355, p.i5170

2016

Volltextzugriff (PDF)

Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Mitigation Strategies on a University Campus Using an Agent-Based Network Model

Clinical infectious diseases, 2021-11, Vol.73 (9), p.1735-1741

2021

Volltextzugriff (PDF)

Safe reopening of college campuses during COVID-19: The University of California experience in Fall 2020

PloS one, 2021-11, Vol.16 (11), p.e0258738-e0258738

2021

Volltextzugriff (PDF)

The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

The Lancet (British edition), 2022-01, Vol.399 (10319), p.61-116

2022

Volltextzugriff (PDF)

Cost-effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States

Clinical infectious diseases, 2021-11, Vol.73 (9), p.e3355-e3357

2021

Volltextzugriff (PDF)

The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention

Current opinion in HIV & AIDS, 2015-09, Vol.10 (5), p.374

2015

Volltextzugriff (PDF)

Sustained Impact of the Coronavirus Disease 2019 Pandemic on Hepatitis C Virus Treatment Initiations in the United States

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e955-e961

2022

Volltextzugriff (PDF)

Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection

PloS one, 2019-06, Vol.14 (6), p.e0217964-e0217964

2019

Volltextzugriff (PDF)

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale‐up in the age of direct‐acting antivirals

Hepatology (Baltimore, Md.), 2013-11, Vol.58 (5), p.1598-1609

2013

Volltextzugriff (PDF)

Opioid agonist treatment scale-up and the initiation of injection drug use: A dynamic modeling analysis

PLoS medicine, 2019-11, Vol.16 (11), p.e1002973

2019

Volltextzugriff (PDF)

Mathematical modelling of hepatitis C treatment for injecting drug users

Journal of theoretical biology, 2011-04, Vol.274 (1), p.58-66

2011

Volltextzugriff (PDF)

How to eliminate HCV infection by antiviral treatment

Journal of hepatology, 2017-07, Vol.67 (1), p.5-6

2017

Volltextzugriff (PDF)

Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights

Clinical infectious diseases, 2016-05, Vol.62 (9), p.1072-1080

2016

Volltextzugriff (PDF)

Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis

PloS one, 2022-05, Vol.17 (5), p.e0267853-e0267853

2022

Volltextzugriff (PDF)

The estimated hepatitis C seroprevalence and key population sizes in San Diego in 2018

PloS one, 2021-06, Vol.16 (6), p.e0251635

2021

Volltextzugriff (PDF)

Annual N95 respirator fit-testing: an unnecessary burden on healthcare

Infection control and hospital epidemiology, 2024-02, Vol.45 (2), p.250-252

2024

Volltextzugriff (PDF)

1 – 25 von 619

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(593)
Mit Volltextzugriff
(542)

Publikationsform

Artikel
(619)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(19)
Clinical Infectious Diseases
(17)
Clinical Infectious Diseases/clinical Infectious Diseases
(16)
Bmj Open
(15)
Addiction
(14)
The Lancet
(14)
Journal Of Clinical Oncology
(13)
Cochrane Database Of Systematic Reviews
(12)
Cochrane Library
(12)
Lancet
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cost-effectiveness of Universal Hepatitis C Virus Screening of Pregnant Women in the United States

Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region

Responding to global stimulant use: challenges and opportunities

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia

Mathematical modeling of hepatitis c virus (HCV) prevention among people who inject drugs: A review of the literature and insights for elimination strategies

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy

The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?

Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review

Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Mitigation Strategies on a University Campus Using an Agent-Based Network Model

Safe reopening of college campuses during COVID-19: The University of California experience in Fall 2020

The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

Cost-effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States

The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention

Sustained Impact of the Coronavirus Disease 2019 Pandemic on Hepatitis C Virus Treatment Initiations in the United States

Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale‐up in the age of direct‐acting antivirals

Opioid agonist treatment scale-up and the initiation of injection drug use: A dynamic modeling analysis

Mathematical modelling of hepatitis C treatment for injecting drug users

How to eliminate HCV infection by antiviral treatment

Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights

Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis

The estimated hepatitis C seroprevalence and key population sizes in San Diego in 2018

Annual N95 respirator fit-testing: an unnecessary burden on healthcare

Aktive Filter

Suchergebnisse filtern